The Role of Microbiota and Probiotics on the Gastrointestinal Health: Prevention of Pathogen Infections

Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease

Volumn , Issue , 2013, Pages 201-213

  Collado, M C ^a,b   Grzeskowiak l ^b   Salminen, S ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885089918     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397154-8.00026-9     Document Type: Chapter

References (48)

1. Allen S.J., Martinez E.G., Gregorio G.V., Dans L.F. Probiotics for treating acute infectious diarrhoea. Cochrane Database Systematic Review 2010, 10(11):CD003048.
2. Boyle R.J., Bath-Hextall F.J., Leonardi-Bee J., Murrell D.F., Tang M.L. Probiotics for the treatment of eczema: a systematic review. Clinical and Experimental Allergy 2009, 39(8):1117-1127.
3. Chen H., Hoover D.G. Bacteriocins and their food applications. Comprehensive Reviews in Food Science and Food Safety 2003, 2:82-100.
4. Collado M.C., Isolauri E., Salminen S., Sanz Y. The impact of probiotic on gut health. Current Drug Metabolism 2009, 10(1):68-78.
5. Collado M.C., Meriluoto J., Salminen S. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Letters in Applied Microbiology 2007, 45(4):454-460.
6. Corr S.C., Hill C., Gahan C.G. Chapter 1 understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Advances in Food and Nutrition Research 2009, 56:1-15.
7. Deshpande G., Rao S., Patole S., Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010, 125(5):921-930.
8. Dewhirst F.E., Chen T., Izard J., et al. The human oral microbiome. Journal of Bacteriology 2010, 192(19):5002-5017.
9. El-Nezami H.S., Polychronaki N.N., Ma J., et al. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. American Journal of Clinical Nutrition 2006, 83(5):1199-1203.
10. FAO/WHO (2002). Guidelines for the evaluation of probiotics in food. Food and Agricultural Organization of the United Nations and World Health Organization. Working Group Report 2002.
11. Fujiwara S., Hashiba H., Hirota T., Forstner J.F. Inhibition of the binding of enterotoxigenic Escherichia coli Pb176 to human intestinal epithelial cell line HCT-8 by an extracellular protein fraction containing BIF of Bifidobacterium longum SBT2928: suggestive evidence of blocking of the binding receptor gangliotetraosylceramide on the cell surface. International Journal of Food Microbiology 2001, 67:97-106.
12. Gill S.R., Pop M., Deboy R.T., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312(5778):1355-1359.
13. Giralt J., Regadera J.P., Verges R., et al. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Radiation Oncology Biology Physics 2008, 71(4):1213-1219.
14. Grice E.A., Segre J.A. The skin microbiome. Nature Reviews Microbiology 2011, 9(4):244-253.
15. Grześkowiak Ł., Isolauri E., Salminen S., Gueimonde M. Manufacturing process influences properties of probiotic bacteria. British Journal of Nutrition 2011, 105(6):887-894.
16. Guandalini S. Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Expert Review of Clinical Immunology 2010, 6(1):47-54.
17. Gueimonde M., Ouwehand A., Huhtinen H., Salminen E., Salminen S. Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World Journal of Gastroenterology 2007, 13(29):3985-3989.
18. Heijtz R.D., Wang S., Anuar F., et al. Normal gut microbiota modulates brain development and behavior. Proceedings of the National Academy of Sciences USA 2011, 108(7):3047-3052.
19. Iannitti T., Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clinical Nutrition 2010, 29(6):701-725.
20. Kajander K., Myllyluoma E., Rajilić-Stojanović M., et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Alimentary Pharmacology and Therapeutics 2008, 27(1):48-57.
21. Kalliomäki M., Salminen S., Arvilommi H., et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001, 357:1076-1079.
22. Kirjavainen P.V., Pautler S., Baroja M.L., et al. Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections. Clinical and Vaccine Immunology 2009, 16(1):29-36.
23. Lionetti E., Indrio F., Pavone L., et al. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Helicobacter 2010, 15(2):79-87.
24. Lyra A., Krogius-Kurikka L., Nikkilä J., et al. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterology 2010, 10:110.
25. Marschan E., Kuitunen M., Kukkonen K., et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clinical and Experimental Allergy 2008, 38(4):611-618.
26. Nesser J.-R., Granato D., Rouvet M., et al. Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. Glycobiology 2000, 10:1193-1199.
27. Neufeld K.A., Foster J.A. Effects of gut microbiota on the brain: implications for psychiatry. Journal of Psychiatry & Neuroscience 2009, 34(3):230-231.
28. Nybom S.M., Salminen S.J., Meriluoto J.A. Specific strains of probiotic bacteria are efficient in removal of several different cyanobacterial toxins from solution. Toxicon 2008, 52(2):214-220.
29. O'Flaherty S., Saulnier D.M., Pot B., Versalovic J. How can probiotics and prebiotics impact mucosal immunity?. Gut Microbes 2010, 1(5):293-300.
30. Ohland C.L., Macnaughton W.K. Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology - Gastrointestinal and Liver Physiology 2010, 298(6):G807-G819.
31. Pan S.J., Kuo C.H., Lam K.P., et al. Probiotics and allergy in children - an update review. Pediatric Allergy and Immunology 2010, 21(4 Pt 2):e659-e666.
32. Parkes G.C., Sanderson J.D., Whelan K. Treating irritable bowel syndrome with probiotics: the evidence. Proceedings of the Nutrition Society 2010, 69(2):187-194.
33. Patel R.M., Lin P.W. Developmental biology of gut-probiotic interaction. Gut Microbes 2010, 1(3):186-195.
34. Paton A.W., Morona R., Paton J.C. Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infections. Bioengineered Bugs 2010, 1(3):172-177.
35. Preidis G.A., Hill C., Guerrant R.L., et al. Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 2011, 140(1):8-14.
36. Reid G., Younes J.A., Van der Mei H.C., et al. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nature Reviews Microbiology 2011, 9(1):27-38.
37. Rose M.A., Stieglitz F., Köksal A., et al. Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk. Clinical and Experimental Allergy 2010, 40(9):1398-1405.
38. Salminen S., Nybom S., Meriluoto J., et al. Interaction of probiotics and pathogens - benefits to human health?. Current Opinion in Biotechnology 2010, 21(2):157-167.
39. Salonen A., de Vos W.M., Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010, 156(Pt 11):3205-3215.
40. Sánchez B., Urdaci M.C., Margolles A. Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa-bacteria interactions. Microbiology 2010, 156(Pt 11):3232-3242.
41. Sekirov I., Russell S.L., Antunes L.C., Finlay B.B. Gut microbiota in health and disease. Physiological Reviews 2010, 90(3):859-904.
42. Sleator R.D., Hill C. New frontiers in probiotic research. Letters in Applied Microbiology 2008, 46:143-147.
43. Szajewska H. Advances and limitations of evidence-based medicine - impact for probiotics. Annals of Nutrition and Metabolism 2010, 57:6-9.
44. Tang M.L., Lahtinen S.J., Boyle R.J. Probiotics and prebiotics: clinical effects in allergic disease. Current Opinion in Pediatrics 2010, 22(5):626-634.
45. Twetman L., Larsen U., Fiehn N.E., Stecksen-Blicks C., Twetman S. Coaggregation between probiotic bacteria and caries-associated strains: an in vitro study. Acta Odontologica Scandinavica 2009, 27:1-5.
46. Vanderploeg R., Panaccione R., Ghosh S., Rioux K. Influences of intestinal bacteria in human inflammatory bowel disease. Infectious Disease Clinics of North America 2010, 24(4):977-993.
47. Vliagoftis H., Kouranos V.D., Betsi G.I., Falagas M.E. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Annals of Allergy, Asthma & Immunology 2008, 101(6):570-579.
48. Voltan S., Castagliuolo I., Elli M., et al. Aggregating phenotype in Lactobacillus crispatus determines intestinal colonization and TLR2 and TLR4 modulation in murine colonic mucosa. Clinical and Vaccine Immunology 2007, 14(9):1138-1148.